[90Y glass microspheres intraradiopraxis of advanced hepatic carcinoma].
OBJECTIVE
To evaluate intraradiopraxis with (90)Y glass microspheres for advanced hepatic carcinoma.


METHODS
28 patients were divided into two group: A treated by (90)Y and hepatic artery embolism and chemotherapy (HAEC) (n = 13), and B by (90)Y and hepatic artery embolism (HAE) (n = 15), and 15 cases (group C) only treated by HACE simultaneously were used as controls. The average age, course, and diameter of tumor were similar in all groups (P > 0.05).


RESULTS
The effective rate of the group A and B was 61.5% and 66.6% respectively, and that of the group C was only 33.3% (P < 0.001). The average survival time of the group A and B was 9.86 and 11.9 months respectively, and that of the group C was only 4.5 months (P < 0.001).


CONCLUSIONS
The intraradiopraxis with (90)Y glass microsphere would be a valuable method for patients with hypo-leukocyte count, insensitive to chemotherapy or resistant to chemotherapy.
Huang
C
C
Department of Hepatobiliary Surgery, Union Hospital, Fujian Medical University, Fuzhou 350001.
Huang
J
J
Yang
W
W
Chen
Y
Y
Shen
J
J
Chen
W
W
Yang
F
F
Chen
H
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001918:Brachytherapy; D006528:Carcinoma, Hepatocellular / Q000532:radiotherapy* / Q000628:therapy; D016461:Chemoembolization, Therapeutic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000532:radiotherapy* / Q000628:therapy; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D016896:Treatment Outcome; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
D015021:Yttrium Radioisotopes